Skip to content

Corvus Pharmaceuticals, Inc.: filings

Every Corvus Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-06fiscal Q2 2026421150001104659-26-091975
10-Q2026-05-07fiscal Q1 202643880001104659-26-057100
10-K2026-03-12fiscal FY 2025421050001104659-26-027047
10-Q2025-11-04fiscal Q3 2025411160001104659-25-106259
10-Q2025-08-07fiscal Q2 2025421130001558370-25-010755
10-Q2025-05-08fiscal Q1 202539790001558370-25-006966
10-K2025-03-25fiscal FY 202439990001558370-25-003621
10-Q2024-11-12fiscal Q3 2024401120001558370-24-015306
10-Q2024-08-06fiscal Q2 2024401080001558370-24-011076
10-Q2024-05-07fiscal Q1 202439800001558370-24-007093
10-K2024-03-19fiscal FY 2023391000001558370-24-003567
10-Q2023-11-07fiscal Q3 2023381090001558370-23-017981
10-Q2023-08-08fiscal Q2 2023381040001558370-23-013914
10-Q2023-05-08fiscal Q1 202337760001558370-23-008503
10-K2023-03-28fiscal FY 2021401030001558370-23-004792
10-Q2022-11-03fiscal Q3 2022391090001558370-22-016233
10-Q2022-08-08fiscal Q2 2022391060001558370-22-012619
10-Q2022-05-05fiscal Q1 202238790001558370-22-007374
10-K2022-03-10fiscal FY 2021411360001558370-22-003281
10-Q2021-11-01fiscal Q3 202135970001558370-21-013913
10-Q2021-08-02fiscal Q2 202134910001558370-21-009818
10-Q2021-04-29fiscal Q1 202134700001558370-21-005258
10-K2021-03-25fiscal FY 2020361060001558370-21-003462
10-Q2020-10-29fiscal Q3 202034960001558370-20-012039
10-Q2020-07-30fiscal Q2 202034910001558370-20-008756
10-Q2020-04-30fiscal Q1 202034700001558370-20-004797
10-K2020-03-09fiscal FY 2019381120001558370-20-002232
10-Q2019-10-29fiscal Q3 201936970001558370-19-009354
10-Q2019-08-01fiscal Q2 201936920001558370-19-006824
10-Q2019-05-09fiscal Q1 201936710001558370-19-004697
10-K2019-03-07fiscal FY 2018351080001558370-19-001660
10-Q2018-11-01fiscal Q3 201833810001558370-18-008268
10-Q2018-08-02fiscal Q2 201833810001558370-18-006236
10-Q2018-05-03fiscal Q1 201831630001104659-18-030262
10-K2018-03-01fiscal FY 2017341050001047469-18-001209
10-Q2017-11-02fiscal Q3 201730710001104659-17-065655
10-Q2017-08-03fiscal Q2 201730710001104659-17-049313
10-Q2017-05-04fiscal Q1 201726530001104659-17-029890
10-K2017-03-10fiscal FY 201628750001047469-17-001459
10-Q2016-11-03fiscal Q3 201625610001104659-16-154578
10-Q2016-08-04fiscal Q2 201626650001104659-16-137057
10-Q2016-05-05fiscal Q1 201626530001104659-16-118308

Inspect the source

Entity
Corvus Pharmaceuticals, Inc. / CIK 0001626971
Captured
2026-09-21T17:21:55.204Z
SEC response SHA-256
efaff8dff6bd932c7ac2851cff10f1e493b250491e3b60ca38d6cd7189bac6f4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001626971.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))